![Rhea Williams](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Rhea Williams formerly worked at Secord, Inc., as Chief Executive Officer and Skye Bioscience, Inc., as Head-Regulatory Affairs & Quality Assurance from 2021 to 2024.
Ms. Williams received her graduate degree from The Trustees of Columbia University in The City of New York and undergraduate degree from the University of Pennsylvania.
| Sociétés | Poste | Fin |
|---|---|---|
| SKYE BIOSCIENCE, INC. | Conseiller Juridique Général | 01/02/2024 |
Secord, Inc.
 Secord, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in pharmaceutical consulting, FDA electronic submission and publishing | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 4 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Skye Bioscience, Inc.
 Skye Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets cannabinoid derivatives to treat ophthalmic disorders | Health Technology |
Secord, Inc.
Secord, Inc. Miscellaneous Commercial ServicesCommercial Services Specializes in pharmaceutical consulting, FDA electronic submission and publishing | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
